AI Summary
✦ ClarthaAlkyl Amines Chemicals is a specialty chemicals manufacturer supplying aliphatic amines, amine derivatives, and other specialty chemicals. Aliphatic amines form the core portfolio, while derivatives and products such as acetonitrile serve industrial applications. No major recent development provides a clear catalyst for revenue or margin expansion. Revenue declined 2.3% year-on-year, while profit fell 3.3%. Margins remained stable despite weaker sales and earnings, indicating limited operating deterioration but no near-term acceleration. ROE and debt-to-equity data are unavailable, preventing assessment of capital efficiency and leverage effects. At 43.1x earnings, the shares appear rich relative to current negative growth and the sector’s cyclical specialty-chemical backdrop. Neutral sentiment is appropriate until demand improves or new capacity and products support stronger earnings growth.
Price Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 3 analysts
Fundamentals
Fundamentals institutional score is 98 using growth durability 98.3.
Valuation
Valuation institutional score is 67 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 13 using mean target upside -11.3%; dispersion penalty 25.4; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 47 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
This data source has not been supplied for the decision payload.
Signal Summary
Market intelligence remains Neutral. fundamentals and valuation provide support, while analyst consensus and technical structure remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 0.3% below historical median. Valuation is declining — currently in the fair zone (z-score: +0.06). Confidence: 86%.
Live forward EPS implies next-12-month EPS of ₹46.13. Applying the stock's normalized valuation corridor produces a fair range of ₹1,815.22 to ₹2,236.84, with base value near ₹2,053.71 (+5.5% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹46.13
Forward P/E
42.2x
Base Fair Value
₹2,053.71
Fair Range
₹1,815.22 - ₹2,236.84
Upside To Base
+5.5%
Estimate Source
Live forward EPS
Growth Estimate
-3.5%
5Y Average
51.61
Current
44.37
Overvalued
48.49
Undervalued
39.35
5Y Average
6.32
Current
6.50
Overvalued
6.94
Undervalued
5.70
5Y Average
7.55
Current
6.49
Overvalued
8.75
Undervalued
6.11
Peers & Comparison
Sector: Materials · Theme: Specialty Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
SUPREME PETROCHEM LIMITED SPLPETROSpecialty Chemicals | +23.7% | 8.5% | 26.8x Undervalued | -57% vs avg | -4.8% |
FINE ORGANIC IND. LTD. FINEORGSpecialty Chemicals | +22.1% | 17.8% | 37.6x Undervalued | -40% vs avg | +5.6% |
CLEAN SCIENCE & TECH LTD CLEANSpecialty Chemicals | +10.5% | 23.7% | 36.6x Undervalued | -41% vs avg | -30.7% |
ANUPAM RASAYAN INDIA LTD ANURASSpecialty Chemicals | +27.5% | 7.2% | 78.2x Premium | +26% vs avg | +6.7% |
GALAXY SURFACTANTS LTD GALAXYSURFSpecialty Chemicals | +14.8% | 5.1% | 27.0x Undervalued | -57% vs avg | -14.4% |
NAVIN FLUORINE INT. LTD NAVINFLUORSpecialty Chemicals | +44.1% | 21.7% | 53.5x Fair | -14% vs avg | +67.4% |
NEOGEN CHEMICALS LIMITED NEOGENSpecialty Chemicals | +34.0% | 3.8% | 147.5x Premium | +137% vs avg | +50.8% |
AETHER INDUSTRIES LIMITED AETHERSpecialty Chemicals | +27.5% | 19.1% | 91.2x Premium | +46% vs avg | +116.4% |
ALKYL AMINES CHEM. LTD trades at a discount (44.6x vs peer avg 62.3x), suggesting potential undervaluation relative to the Specialty Chemicals cohort. Peers include SUPREME PETROCHEM LIMITED, FINE ORGANIC IND. LTD., CLEAN SCIENCE & TECH LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹528 CrJun 2026Latest net profit
₹95 CrJun 2026Latest EPS
₹18.50Jun 2026Net margin
25.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 410 | 352 | 322 | 357 | 400 | 415 | 371 | 386 | 406 | 389 | 354 | 387 | 528 |
| Expenses + | 336 | 304 | 262 | 288 | 321 | 341 | 301 | 318 | 329 | 319 | 287 | 316 | 394 |
| Operating Profit | 74 | 48 | 60 | 69 | 79 | 74 | 71 | 68 | 77 | 70 | 67 | 71 | 134 |
| OPM % | 18% | 14% | 19% | 19% | 20% | 18% | 19% | 18% | 19% | 18% | 19% | 18% | 25% |
| Other Income + | 5 | 2 | 5 | 3 | 5 | 9 | 7 | 9 | 8 | 7 | 8 | 8 | 9 |
| Interest | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 12 | 13 | 17 | 17 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Profit before tax | 66 | 36 | 46 | 53 | 66 | 64 | 59 | 59 | 66 | 59 | 57 | 61 | 125 |
| Tax % | 25% | 25% | 28% | 28% | 26% | 26% | 26% | 22% | 25% | 27% | 26% | 25% | 24% |
| Net Profit + | 50 | 27 | 33 | 38 | 49 | 47 | 44 | 46 | 49 | 43 | 42 | 45 | 95 |
| EPS in Rs | 9.74 | 5.33 | 6.54 | 7.52 | 9.56 | 9.28 | 8.56 | 9.00 | 9.67 | 8.40 | 8.26 | 8.87 | 18.50 |
| Raw PDF | |||||||||||||
| YOY Sales Growth % | -13.44% | -13.84% | -17.07% | -13.54% | -2.46% | 17.82% | 15.26% | 8.25% | 1.46% | -6.14% | -4.63% | 0.22% | 30.20% |
| Material Cost % | 55% | 54% | 52% | 51% | 53% | 55% | 52% | 54% | 54% | 53% | 52% | 54% | 51% |
| Employee Cost % | 6% | 7% | 7% | 7% | 6% | 6% | 7% | 6% | 7% | 7% | 8% | 7% | 7% |
| Other income normal | 5.48 | 2.35 | 4.62 | 2.61 | 4.72 | 9.16 | 6.60 | 9.32 | 7.96 | 7.42 | 8.01 | 8.27 | 9.30 |
| Profit excl Excep | 50 | 27 | 33 | 38 | 49 | 47 | 44 | 46 | 49 | 43 | 42 | 45 | 95 |
| Profit for PE | 50 | 27 | 33 | 38 | 49 | 47 | 44 | 46 | 49 | 43 | 42 | 45 | 95 |
| Profit for EPS | 50 | 27 | 33 | 38 | 49 | 47 | 44 | 46 | 49 | 43 | 42 | 45 | 95 |
| YOY Profit Growth % | -39% | -48% | -27% | -21% | -2% | 74% | 31% | 20% | 1% | -10% | -3% | -1% | 91% |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Board Meeting Outcome for Outcome Of Board Meeting - Financial Results